Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 10, 2003 14:17 ET | Source: Insert Therapeutics, Inc.

Insert Therapeutics Presents Capabilities and Versatility of Drug Delivery Platform

PASADENA, Calif., Sept. 10, 2003 (PRIMEZONE) -- Insert Therapeutics, Inc. Senior Scientist Jianjun Cheng, PhD, presented data this week at the American Chemical Society Meeting in New York City...
July 24, 2003 08:00 ET | Source: Insert Therapeutics, Inc.

Insert Therapeutics Receives Phase I FLAIR Grant to Further its Novel, Non-Viral Gene Delivery System for Treating Cancer; National Cancer Institute Awards Phase I Grant for Cyclosert Delivery of Interferon Alpha Gene

PASADENA, Calif., July 24, 2003 (PRIMEZONE) -- Insert Therapeutics, Inc. announced that it has been awarded a Phase I Flexible System to Advance Innovative Research (FLAIR) grant from the National...
July 22, 2003 08:00 ET | Source: Insert Therapeutics, Inc.

Insert Therapeutics Describes In Vivo Performance and Versatility of Drug Delivery Platform

PASADENA, Calif., Jul 22, 2003 (PRIMEZONE) -- Insert Therapeutics, Inc. President and Chief Executive Officer, Leonard R. Borrmann, Pharm.D., presented data today demonstrating the flexibility and...
June 24, 2003 10:00 ET | Source: Insert Therapeutics, Inc.

Insert Therapeutics Reports In Vivo Performance of Drug Delivery Platform Assembled with a Nucleic Acid

PASADENA, Calif., June 24, 2003 (PRIMEZONE) -- Insert Therapeutics, Inc. reported that its Senior Scientist Dr. Suzie Hwang Pun presented data on the company's proprietary Cyclosert(tm) drug delivery...